Chimie ParisTech, PSL University, CNRS, Institute of Chemistry for Life and Health Sciences, Laboratory for Inorganic Chemical Biology, 75005, Paris, France.
MOE Key Laboratory of Bioinorganic and Synthetic Chemistry, School of Chemistry, Sun Yat-Sen University, 510275, Guangzhou, People's Republic of China.
Chemistry. 2021 Jan 4;27(1):362-370. doi: 10.1002/chem.202003486. Epub 2020 Nov 17.
During the last decades, photodynamic therapy (PDT), an approved medical technique, has received increasing attention to treat certain types of cancer. Despite recent improvements, the treatment of large tumors remains a major clinical challenge due to the low ability of the photosensitizer (PS) to penetrate a 3D cellular architecture and the low oxygen concentrations present in the tumor center. To mimic the conditions found in clinical tumors, exceptionally large 3D multicellular tumor spheroids (MCTSs) with a diameter of 800 μm were used in this work to test a series of new Ru polypyridine complexes as one-photon and two-photon PSs. These metal complexes were found to fully penetrate the 3D cellular architecture and to generate singlet oxygen in the hypoxic center upon light irradiation. While having no observed dark toxicity, the lead compound of this study showed an impressive phototoxicity upon clinically relevant one-photon (595 nm) or two-photon (800 nm) excitation with a full eradication of the hypoxic center of the MCTSs. Importantly, this efficacy was also demonstrated on mice bearing an adenocarcinomic human alveolar basal epithelial tumor.
在过去的几十年中,光动力疗法(PDT)作为一种经过批准的医学技术,受到了越来越多的关注,用于治疗某些类型的癌症。尽管最近有所改进,但由于光敏剂(PS)穿透 3D 细胞结构的能力低,以及肿瘤中心存在低氧浓度,治疗大肿瘤仍然是一个主要的临床挑战。为了模拟临床肿瘤中发现的情况,本工作中使用了直径为 800 μm 的异常大的 3D 多细胞肿瘤球体(MCTS)来测试一系列新的 Ru 多吡啶配合物作为单光子和双光子 PS。这些金属配合物被发现完全穿透 3D 细胞结构,并在光照下于缺氧中心生成单线态氧。虽然没有观察到暗毒性,但本研究的先导化合物在临床相关的单光子(595nm)或双光子(800nm)激发下表现出令人印象深刻的光毒性,完全消除了 MCTS 的缺氧中心。重要的是,这种疗效也在携带人腺癌细胞性肺泡基底上皮肿瘤的小鼠中得到了证明。